1
|
Zhou YM, Yang RQ, Tao SC, Li Z, Zhang Q, Gao HF, Zhang ZW, Du JY, Zhu PX, Ren LL, Zhang L, Wang D, Guo L, Wang YB, Guo Y, Zhang Y, Zhao CZ, Wang C, Jiang D, Liu YH, Yang HW, Rong L, Zhao YJ, An S, Li Z, Fan XD, Wang JW, Cheng Y, Liu O, Zheng Z, Zuo HC, Shan QZ, Ruan L, Lü ZX, Hung T, Cheng J. The design and application of DNA chips for early detection of SARS-CoV from clinical samples. J Clin Virol 2005; 33:123-31. [PMID: 15911427 PMCID: PMC7108259 DOI: 10.1016/j.jcv.2004.10.019] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2004] [Revised: 08/28/2004] [Accepted: 10/17/2004] [Indexed: 11/30/2022]
Abstract
Background: SARS coronavirus has been identified as the cause of severe acute respiratory syndrome (SARS). Few tests allow confirmation or exclusion of SARS within the first few days of infection. A gene chip is a useful tool for the study of microbial infections mainly for its capability of performing multi-target analysis in a single test. Objectives: Investigate the possibility of early detection of SARS virus from clinical samples using the gene chip-based method. Study design: We purified RNA from SARS-CoV obtained from routinely collected peripheral blood and sputum samples of 34 patients who had been identified as probable SARS patients by following the interim U.S. case definition. Four segments of the SARS-CoV were amplified using reverse transcription-nested PCR and the products examined using the 70-mer gene chips for SARS-CoV detection. Results: A blind-test of both peripheral blood and sputum specimens lead to the positive detection of SARS-CoV in 31 out of 34 patients. SARS-CoV was not found in peripheral blood or sputum specimens from three patients. Two of the 34 patients were only 3 days post-onset of symptoms and were subsequently confirmed to be SARS positive. Our results indicate that the gene chip-based molecular test is specific for SARS-CoV and allows early detection of patients with SARS with detection rate about 8% higher than the single PCR test when the sputum sample is available.
Collapse
Affiliation(s)
- Yi-ming Zhou
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Ren-quan Yang
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Sheng-ce Tao
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Ze Li
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Qiong Zhang
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Hua-fang Gao
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Zhi-wei Zhang
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Jian-yu Du
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Pei-xuan Zhu
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Li-li Ren
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Liang Zhang
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Dong Wang
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Lan Guo
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Yan-bin Wang
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Yong Guo
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Yan Zhang
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
| | - Chuan-zan Zhao
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Can Wang
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Di Jiang
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Yan-hua Liu
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Hua-wei Yang
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Li Rong
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Yan-jun Zhao
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Shuang An
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Zhe Li
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Xiao-dong Fan
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
| | - Jian-wei Wang
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
- Co-corresponding author. Tel.: +86 10 63581580; fax: +86 10 63529809.
| | - Yun Cheng
- No. 302 Hospital of the People's Liberation Army, Beijing 100039, China
| | - Ou Liu
- Tsinghua University Jiuxianqiao Hospital, Beijing 100016, China
| | - Zhong Zheng
- Tsinghua University Yuquanlu Hospital, Beijing 100039, China
| | - Huan-cong Zuo
- Tsinghua University Yuquanlu Hospital, Beijing 100039, China
| | - Quan-zhong Shan
- Tsinghua University Jiuxianqiao Hospital, Beijing 100016, China
- Co-corresponding author. Tel.: +86 10 64361322; fax: +86 10 64361322.
| | - Li Ruan
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Zhan-xiu Lü
- No. 302 Hospital of the People's Liberation Army, Beijing 100039, China
| | - Tao Hung
- Institute of Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
| | - Jing Cheng
- State Key Laboratory of Biomembrane and Membrane Biotechnology, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
- National Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
- CapitalBio Corporation, 18 Life Science Parkway, Changping District, Beijing 102206, China
- Corresponding author. Tel.: +86 10 62772239; fax: +86 10 62773059.
| |
Collapse
|